Sort
23,748 grants matching “melanoma”
GRNs Guiding Cranial Versus Trunk Neural Crest Formation
$312,134Marianne Bronner · California Institute Of Technology · P01 · FY2014 · HD
Combined CD40 activation and CTLA4 blockade in melanoma
$312,080Robert H Vonderheide · University Of Pennsylvania · R01 · FY2013 · CA
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2019 · CA
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2020 · CA
Regulation of Mutationally Activated Gq/11
$312,000Philip B Wedegaertner · Thomas Jefferson University · R01 · FY2024 · GM
Regulation of Mutationally Activated Gq/11
$312,000Philip B Wedegaertner · Thomas Jefferson University · R01 · FY2021 · GM
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2021 · CA
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2023 · CA
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2022 · CA
Regulation of Mutationally Activated Gq/11
$312,000Philip B Wedegaertner · Thomas Jefferson University · R01 · FY2022 · GM
Regulation of Mutationally Activated Gq/11
$312,000Philip B Wedegaertner · Thomas Jefferson University · R01 · FY2023 · GM
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to RAF inhibitors
$311,976Andrew E Aplin · Thomas Jefferson University · R01 · FY2014 · CA
ISG15 and protein ISGylation in Cancer
$311,976Dong-Er Zhang · University Of California, San Diego · R01 · FY2014 · CA
Melanocortin-1 Receptor Targeted Ultrasmall Silica nanoparticles for Alpha- and
$311,972Thomas P Quinn · Sloan-Kettering Inst Can Research · U54 · FY2015 · CA
HLA CLASS I PEPTIDE COMPLEX ADNORMALITIES IN MELANOMA
$311,966Roswell Park Cancer Institute Corp · R01 · FY2001 · CA
FUNCTION OF ATF2--URE BINDING PROTEIN IN HUMAN MELANOMA
$311,960Mount Sinai School Of Medicine Of Nyu · R01 · FY2000 · CA
Tumor Stroma Interactions: Wound Promoted Tumor Growth
$311,930John Niederhuber · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
In-situ activation of antitumor effectors
$311,890Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2002 · CA
Lymph Node Alterations in Cancer
$311,887M Alanna Ruddell · University Of Washington · R01 · FY2014 · CA
THE ROLE OF MAP KINASE PATHWAY ACTIVATION IN THE TREATMENT OF NRAS-MUTANT AND THERAPY-RESISTANT BRAF-MUTANT MELANOMA
$311,862The Broad Institute, Inc · · FY2022 · Defense Health Agency
Tumor Suppressor Genes in Heritable Melanoma Models
$311,860Rodney S Nairn · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Melanocortin-1 Receptor Targeted Ultrasmall Silica nanoparticles for Alpha- and
$311,857Thomas P Quinn · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
POLYAMINE ANALOG AND INHIBITOR REGULATION OF CELL CYCLE
$311,831Roswell Park Cancer Institute Corp · R01 · FY2003 · CA
Pathways from genotype and environment to melanoma
$311,824Queensland Institute Of Medical Research · R01 · FY2001 · CA
Prevention of UV-carcinogenesis through DNA repair-dependent immunomodulation
$311,824Santosh Kumar Katiyar · University Of Alabama At Birmingham · R01 · FY2013 · CA